Is there a role for 5-HT1A agonists in the treatment of depression?

This publication has 74 references indexed in Scilit:

• Mirtazapine compared with paroxetine in major depression.
  The Journal of Clinical Psychiatry, 2000
• The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial
  Biological Psychiatry, 1999
• Selective Activation of Postsynaptic 5-HT1A Receptors Induces Rapid Antidepressant Response
  Neuropsychopharmacology, 1997
• Current advances and trends in the treatment of depression
  Trends in Pharmacological Sciences, 1994
• Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1992
• Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine—II. Effects of acute administration of 1-PP and long-term adminstration of tandospirone on noradrenergic neurotransmission
  Neuropharmacology, 1991
• Differential Effect of Gepirone on Presynaptic and Postsynaptic Serotonin Receptors
  Journal of Clinical Psychopharmacology, 1990
• Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
• Modification of 5‐HT neuron properties by sustained administration of the 5‐HT_1A agonist gepirone: Electrophysiological studies in the rat brain
  Synapse, 1987
• Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance
  Brain Research, 1984